↓ Skip to main content

Galcanezumab: First Global Approval

Overview of attention for article published in Drugs, October 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
64 Mendeley
Title
Galcanezumab: First Global Approval
Published in
Drugs, October 2018
DOI 10.1007/s40265-018-1002-7
Pubmed ID
Authors

Yvette N. Lamb

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 64 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 17%
Researcher 8 13%
Student > Master 8 13%
Other 5 8%
Student > Ph. D. Student 4 6%
Other 5 8%
Unknown 23 36%
Readers by discipline Count As %
Medicine and Dentistry 15 23%
Pharmacology, Toxicology and Pharmaceutical Science 11 17%
Biochemistry, Genetics and Molecular Biology 3 5%
Neuroscience 3 5%
Chemistry 2 3%
Other 5 8%
Unknown 25 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2019.
All research outputs
#6,898,881
of 23,109,468 outputs
Outputs from Drugs
#1,202
of 3,289 outputs
Outputs of similar age
#124,511
of 351,030 outputs
Outputs of similar age from Drugs
#19
of 33 outputs
Altmetric has tracked 23,109,468 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,289 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has gotten more attention than average, scoring higher than 62% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,030 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 33 others from the same source and published within six weeks on either side of this one. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.